Cleared Traditional

K770365 - RADIOIMMUNOASSAY DIGOXIN TEST, IN VITRO

K770365 is an FDA 510(k) clearance for RADIOIMMUNOASSAY DIGOXIN TEST, manufactured by Travenol Laboratories, S.A.. The device is a Class 2 Immunology device with product code DPO cleared through the Traditional 510(k) pathway after a 1-day FDA review.

K770365 · Travenol Laboratories, S.A. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1977
Decision
1d
Days
Class 2
Risk

K770365 is an FDA 510(k) clearance for the RADIOIMMUNOASSAY DIGOXIN TEST, IN VITRO. Classified as Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep. (product code DPO), Class II - Special Controls.

Submitted by Travenol Laboratories, S.A. (Mchenry, US). The FDA issued a Cleared decision on February 24, 1977 after a review of 1 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.3320 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Travenol Laboratories, S.A. devices

FDA 510(k) Submission Details - K770365

510(k) Number K770365 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 23, 1977
Decision Date February 24, 1977
Days to Decision 1 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
104d faster than avg
Panel avg: 105d · This submission: 1d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPO Device Classification - Class 2, Special Controls

Product Code DPO Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep.
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DPO Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep.

All 9
Devices cleared under the same product code (DPO) and FDA review panel - the closest regulatory comparables to K770365.
AUTOPAK 12 DIGOXIN TEST DELIVERY SYSTEM
K791325 · Micromedic Systems · Aug 1979
VENTRE/SEP DIGOXIN RADIOIMMUNOASSAY KIT
K791355 · Ventrex Laboratories, Inc. · Aug 1979
IGOXIN SOLID PHASE RIA
K771638 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Oct 1977
DIGOXIN CLASP TM RIA KIT
K770069 · E. R. Squibb & Sons, Inc. · Jan 1977